Assessment of Mesothelioma Symptoms More Accurate With Mixed-Methods Approach
Researchers sought to quantitatively and qualitatively characterize symptoms experienced by patients with malignant pleural mesothelioma.
Diagnosis & Disease Information
Opdivo Plus Yervoy Approved for Malignant Pleural Mesothelioma
The approval was based on a pre-specified interim analysis from the open-label phase 3 CheckMate -743 trial.
Disease-Related Characteristics and Asbestos Exposure in Women With Mesothelioma
In this study, the most common form of the malignant diffuse mesothelioma in women was characterized by pleural location and epitheliolid histology.
Healthcare Professionals Weigh In on Chemotherapy Use In Malignant Pleural Mesothelioma
A survey of healthcare professionals sought to determine their perspectives on aspects of treatment decision-making related to administration of chemotherapy in eligible patients with malignant pleural mesothelioma.
Evolving Role of Radiation Therapy in the Treatment of Mesothelioma
Research into the potential of radiation therapy in the management of mesothelioma may improve the prognosis, and possibly extend progression-free survival, for patients with this incurable cancer.
Pembrolizumab May Help Combat Mesothelioma
Checkpoint inhibitor pembrolizumab appears well-tolerated with antitumor activity in patients with malignant pleural mesothelioma.
Surgery Improves Quality of Life for Patients With Malignant Pleural Mesothelioma
Undergoing pleurectomy and decortication for malignant pleural mesothelioma generally leads to improved quality of life after the surgery.
Modern Management of Malignant Pleural Mesothelioma
[Lung Cancer: Targets and Therapy] This research evaluates the addition of bevacizumab to standard chemotherapy as well as with the use of immune checkpoint inhibitors in malignant pleural mesothelioma (MPM).
Combination of Live Bacterium and Chemotherapy Improves Response Rate in Patient With Pleural Mesothelioma
Patients with malignant pleural mesothelioma (MPM) experienced greater than 90% disease control and 59% response rate after immunotherapy with live bacterium combined with chemotherapy.
Research Shows Drug Inhibits Mesothelioma Growth
A new drug might help successfully treat mesothelioma, one of the deadliest cancers, according to results from cell culture and mouse xenograft models of the disease.
- Loading...
Loading...
Loading... 
Loading...